The health of the aging eye

As people age, the eyes are at risk of a variety of diseases and vision loss, including cataracts and Age-related Macular Degeneration (AMD).1 Lutein and zeaxanthin intake is strongly associated with increasing Macular Pigment Optical Density (MPOD), as they prevent oxidative stress and free radical damage of the macula’s cells.

why floraglo® lutein?

FloraGLO® lutein is demonstrated to increase MPOD and improve visual function.2 A high dietary intake of lutein and zeaxanthin also has been associated with a significant reduction in the risk of progression to cataract surgery, of any cataract, or of any severe cataract.3

36 studies supporting that lutein increases mpod

Have a question?

25 glorious years

25 glorious reasons

These statements have not been evaluated by the US Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

The information on this webpage is a business-to-business information and not intended for the final consumer. Certain statements may not be applicable in all geographical regions. Product labeling and associated claims differs based upon government requirements and country or region specific information should also be considered when labeling or advertising to final consumers.

This web page and its associated brochures and other documents do not constitute or provide scientific or medical advice, diagnosis, or treatment and are distributed without warranty of any kind, either expressly or implied. This web page, its title or contents and associated brochures and other documents do not in any way make recommendations for health or marketing claims by the reader. Country and region specific regulations should be considered in this regard. Each claim or statement about the effectiveness of Kemin products and/or each claim or statement comparing the effectiveness of Kemin products to the effectiveness of other products is expressly limited to the United States, unless otherwise disclosed on the Kemin websites.

References: 

  1. Seddon, J. M. et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 272, 1413–1420 (1994).
  2. Richer, S. et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optom. St Louis Mo 75, 216–230 (2004).
  3. The Age-Related Eye Disease Study 2 (AREDS2) Research Group, Chew EY, SanGiovanni J & et al. Lutein/zeaxanthin for the treatment of age-related cataract: Areds2 randomized trial report no. 4. JAMA Ophthalmol. 131, 843–850 (2013).